Literature DB >> 25332170

Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.

Eric B Dammer1, Andrew K Lee1, Duc M Duong1, Marla Gearing2, James J Lah3, Allan I Levey3, Nicholas T Seyfried1,3.   

Abstract

Abnormal phosphorylation contributes to the formation of neurofibrillary tangles in Alzheimer's disease (AD), but may play other signaling roles during AD pathogenesis. In this study, we employed IMAC followed by LC-MS/MS to identify phosphopeptides from eight individual AD and eight age-matched control postmortem human brain tissues. Using this approach, we identified 5569 phosphopeptides in frontal cortex across all 16 cases in which phosphopeptides represented 80% of all peptide spectral counts collected following IMAC enrichment. Marker selection identified 253 significantly altered phosphopeptides by precursor intensity, changed by at least 1.75-fold relative to controls, with an empirical false discovery rate below 7%. Approximately 21% of all significantly altered phosphopeptides in AD tissue were derived from tau. Of the other 142 proteins hyperphosphorylated in AD, membrane, synapse, cell junction, and alternatively spliced proteins were overrepresented. Of these, we validated differential phosphorylation of HSP 27 (HSPB1) and crystallin-alpha-B (CRYAB) as hyperphosphorylated by Western blotting. We further identified a network of phosphorylated kinases, which coenriched with phosphorylated small HSPs. This supports a hypothesis that a number of kinases are regulating and/or regulated by the small HSP folding network.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  IMAC; MS; Neurodegeneration; Proteostasis; Systems biology

Mesh:

Substances:

Year:  2014        PMID: 25332170      PMCID: PMC4404162          DOI: 10.1002/pmic.201400189

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  42 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 2.  Mapping in vivo signal transduction defects by phosphoproteomics.

Authors:  Taras Stasyk; Lukas A Huber
Journal:  Trends Mol Med       Date:  2011-12-09       Impact factor: 11.951

3.  Comparative gene marker selection suite.

Authors:  Joshua Gould; Gad Getz; Stefano Monti; Michael Reich; Jill P Mesirov
Journal:  Bioinformatics       Date:  2006-05-18       Impact factor: 6.937

4.  Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant.

Authors:  Md Faiz Ahmad; Bakthisaran Raman; Tangirala Ramakrishna; Ch Mohan Rao
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

Review 5.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

6.  Decreased levels of protein kinase C in Alzheimer brain.

Authors:  G Cole; K R Dobkins; L A Hansen; R D Terry; T Saitoh
Journal:  Brain Res       Date:  1988-06-14       Impact factor: 3.252

7.  Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease.

Authors:  H Shinohara; Y Inaguma; S Goto; T Inagaki; K Kato
Journal:  J Neurol Sci       Date:  1993-11       Impact factor: 3.181

8.  Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study.

Authors:  J Y Chin; R B Knowles; A Schneider; G Drewes; E M Mandelkow; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

9.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

Authors:  D P Hanger; K Hughes; J R Woodgett; J P Brion; B H Anderton
Journal:  Neurosci Lett       Date:  1992-11-23       Impact factor: 3.046

10.  Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Authors:  Yair M Gozal; Duc M Duong; Marla Gearing; Dongmei Cheng; John J Hanfelt; Christopher Funderburk; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

View more
  39 in total

1.  FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.

Authors:  Waltraud Mair; Jan Muntel; Katharina Tepper; Shaojun Tang; Jacek Biernat; William W Seeley; Kenneth S Kosik; Eckhard Mandelkow; Hanno Steen; Judith A Steen
Journal:  Anal Chem       Date:  2016-03-07       Impact factor: 6.986

Review 2.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

3.  Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.

Authors:  Ian Diner; Chadwick M Hales; Isaac Bishof; Lake Rabenold; Duc M Duong; Hong Yi; Oskar Laur; Marla Gearing; Juan Troncoso; Madhav Thambisetty; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

4.  Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.

Authors:  Iris J Broce; Chin Hong Tan; Chun Chieh Fan; Iris Jansen; Jeanne E Savage; Aree Witoelar; Natalie Wen; Christopher P Hess; William P Dillon; Christine M Glastonbury; Maria Glymour; Jennifer S Yokoyama; Fanny M Elahi; Gil D Rabinovici; Bruce L Miller; Elizabeth C Mormino; Reisa A Sperling; David A Bennett; Linda K McEvoy; James B Brewer; Howard H Feldman; Bradley T Hyman; Margaret Pericak-Vance; Jonathan L Haines; Lindsay A Farrer; Richard Mayeux; Gerard D Schellenberg; Kristine Yaffe; Leo P Sugrue; Anders M Dale; Danielle Posthuma; Ole A Andreassen; Celeste M Karch; Rahul S Desikan
Journal:  Acta Neuropathol       Date:  2018-11-09       Impact factor: 17.088

5.  AEE788 Inhibits Basal Body Assembly and Blocks DNA Replication in the African Trypanosome.

Authors:  Catherine Sullenberger; Daniel Piqué; Yuko Ogata; Kojo Mensa-Wilmot
Journal:  Mol Pharmacol       Date:  2017-02-28       Impact factor: 4.436

6.  Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.

Authors:  Katherine E Vest; Brittany L Phillips; Ayan Banerjee; Luciano H Apponi; Eric B Dammer; Weiting Xu; Dinghai Zheng; Julia Yu; Bin Tian; Grace K Pavlath; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

7.  Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.

Authors:  Chadwick M Hales; Eric B Dammer; Qiudong Deng; Duc M Duong; Marla Gearing; Juan C Troncoso; Madhav Thambisetty; James J Lah; Joshua M Shulman; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

8.  Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.

Authors:  Paola Merino; Ariel Diaz; Luis Guillermo Manrique; Lihong Cheng; Manuel Yepes
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

Review 9.  Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Authors:  Guillermo Moya-Alvarado; Noga Gershoni-Emek; Eran Perlson; Francisca C Bronfman
Journal:  Mol Cell Proteomics       Date:  2015-12-11       Impact factor: 5.911

10.  Phosphorylated tau interactome in the human Alzheimer's disease brain.

Authors:  Eleanor Drummond; Geoffrey Pires; Claire MacMurray; Manor Askenazi; Shruti Nayak; Marie Bourdon; Jiri Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.